InspireMD Inc Stock Nyse
Equities
US45779A5074
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
03-06 | Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
03-06 | Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M | MT |
Sales 2024 * | 7.09M 9.7M | Sales 2025 * | 14.65M 20.02M | Capitalization | 46.85M 64.03M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 6.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.51% |
Latest transcript on InspireMD Inc
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 11-03-30 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 75 | 20-10-12 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Thomas Kester
BRD | Director/Board Member | 77 | 16-09-05 |
1st Jan change | Capi. | |
---|---|---|
-4.36% | 184B | |
-0.89% | 108B | |
-3.30% | 67.82B | |
+3.92% | 51.05B | |
+8.77% | 44.67B | |
+3.40% | 41.78B | |
+3.22% | 26.78B | |
+4.04% | 26.59B | |
+15.23% | 25.86B |